LRRK2 and Parkinson disease: The discrepancies between previously reported acute effects and the present chronic effects of LRRK2 inhibition may be dependent on compensatory mechanisms after chronic LRRK2 inhibition, or on the limited validity of the AAV overexpression model as a PD model.